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WOMAN WITH ANEMIA AND ABDOMINAL PAIN
Joanna Kipnes, MD, and Marina Serper MD
Case Presentation
The patient is a 36 year-old African American female with a 15
year history of Crohn’s disease complicated by severe perianal
involvement not responsive to steroids or immunomodulating
medication. The patient had undergone a proctocolectomy and
diverting ileostomy two years ago secondary to refractory disease
and had been symptom-free until 6 months prior to admission.
At that time, the patient noted pain, vaginal discharge, and
ulcerations in the perineal region. Three weeks prior to admission,
she began to have almost daily vaginal bleeding as well as
weakness, dizziness, and increased fatigue. She had no subjective
fevers or chills and had no changes in output from the ileostomy.
Outpatient medications included ciprofloxacin and metronidazole
started 3 days ago by her gastroenterologist.
On physical examination, the patient was a well-nourished female
in no apparent distress. Her blood pressure was 126/72 mmHg,
the pulse was 80 beats per minute, the temperature was 98.6° F
and the oxygen saturation was 100% on room air. She was anicteric
with moist mucous membranes and normal skin turgor. On
cardiac examination there was a 1/6 systolic ejection murmur heard
best at the left sternal border. The lungs were clear to auscultation.
The abdomen was soft, diffusely tender, with the ileostomy
draining odorless bilious material. She had normal bowel sounds.
No lower extremity edema and no rashes were present.
Gynecologic examination revealed left labial swelling, and two
ulcerations, 1 to 2 cm in size, between the labia major and minora.
There was another linear midline ulceration extending from the
gluteal cleft to the perineum. At that time, an internal
examination could not be performed secondary to severe pain.
Admission labs were notable for hemoglobin of 5.9 g/dL, MCV
of 60 fl, CRP of 2.3 mg/L, and ESR of 63 mm/hr. A CT scan of
the abdomen and pelvis showed marked distension of the vaginal
lumen and vaginal stenosis likely secondary to inflammation.
The patient’s profound iron deficiency was treated with a blood
transfusion and IV iron. A differential diagnosis for the perineal
lesions included enterovaginal fistulae, cutaneous Crohn’s disease,
Bechet’s disease, and sexually transmitted diseases.
A vaginal exam conducted under anesthesia revealed extensive
linear vulvar ulcerations extending from the perineum to the
gluteal cleft. During the examination a copious amount of green
malodorous fluid was extracted from the vaginal vault. No
fluctuant masses, internal vaginal lesions, or fistulous tracts were
identified. A pelvis MRI showed a vaginocutaneous fistula, but
no communication between the vagina and the GI tract. A small
bowel follow-through showed a normal mucosal pattern and no
enterovaginal fistula. The patient also had a negative charcoal
challenge test in which a tampon was placed in her vagina and
the patient drank activated charcoal. No charcoal was identified
on the tampon (a negative test) indicating that no enterovaginal
fistula was present.

Figure 1. High powered view of vulvar biopsy showing a dense
inflammatory inflitrate, along with giant cells and a granuloma.
This pathology is consistent with Crohn’s disease.
Vulvar biopsy (Figure 1) showed dense diffuse inflammation with
multinucleated giant cells and granulomas consistent with Crohn’s
disease. Further workup for infectious etiologies (HSV, syphilis,
H. ducreyi, Chlamydia, Gonorrhea) was negative. The presence of
histology consistent with Crohn’s disease and the absence of an
enterovaginal fistula established the diagnosis of cutaneous Crohn’s
disease also known in the literature as metastatic Crohn’s disease.

Discussion
Crohn’s disease is a chronic, relapsing disease that may affect any
part of the alimentary tract from the mouth to the anus. Skin
lesions are well recognized as an extra intestinal manifestation of
Crohn’s disease. Cutaneous lesions may be divided on the basis of
whether or not they have a granulomatous histologic appearance.
Lesions without a granulomatous appearance are more common
and include erythema nodosum, pyoderma gangrenosum, Sweet
syndrome, and epidermolysis bullosa acquisita.
Granulomatous cutaneous lesions of Crohn’s disease most
commonly affect the skin through direct contiguous extension
from the involved bowel. However lesions that form noncaseating
granulomas in sites noncontiguous with the gastrointestinal tract
have been termed “metastatic Crohn’s disease.” The lesions of
metastatic Crohn’s disease were first described by Parks et al. in
19651 and have since been reported involving the face, axilla,
pulmonary mucosa, vulva, vagina, penis, scrotum, forearms, shins,
breast, back, perianal region, and groin. The lesions may appear
as ulcers, nodules, ulcers, or plaques.2,3 Because of its variable
appearance it has been misdiagnosed as cellulitis, erysipelas,
lichenoid eruptions, or various sexually transmitted diseases.
Metastatic Crohn’s disease has been reported in the absence of
any active gastrointestinal disease,4 however it more commonly
occurs in those with colonic involvement and does not parallel
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gastrointestinal disease activity.2 Due to the relative rarity of
these noncontiguous granulomatous lesions, there are no
clinical trials to guide current treatment. Therapy with
steroids, metronidazole, azathioprine, sulfasalazine, and
tetracyclines has been used with variable success.2,3
Metastatic Crohn’s disease exhibits variable clinical features
and may resemble many other dermatoses. In this case of a
female patient with active Crohn’s and vulva and perineal
ulcers other diagnoses such as Bechet’s disease and a variety of
sexually transmitted diseases were entertained. The diagnosis
was ultimately made by biopsy of the patient’s lesions. It is

the recommendation of many experts in the field of inflammatory
bowel disease that any unusual cutaneous lesion or any lesion that
doesn’t resolve with standard therapy be biopsied.2,3
■
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INFILTRATED EPINEPHRINE
Utpal Sagar, MD, Bonnie Callahan, MD, and Ted Martynowicz, DO
Case Presentation
The patient is a 67 year-old male with past medical history of
CAD s/p CABG, CHF with EF of 15%, BiV- ICD, who was
recently admitted to an outside hospital in Delaware with SOB
and weakness, and was found to have frequent bouts of VT.
During that hospitalization, he had suffered cardiac arrest as well,
and epinephrine was administered emergently through a
peripheral IV site located in his right hand. He was thereafter
loaded with amiodarone for the ventricular tachycardia. It was
later found that the epinephrine had infiltrated into the skin of
his right hand from the peripheral IV site. Following stabilization
at the outside hospital, the patient requested transfer to
Wilmington VAMC for further treatment and rehabilitation. The
photograph below (obtained with permission), illustrates the vast
degree of skin necrosis and surrounding erythema that resulted
from skin infiltration of epinephrine in this patient.
Vasoactive drugs are often administered immediately before,
during, and after an arrest to support cardiac output. Drugs may
be selected to improve chronotropy, inotropy, or arterial pressure.1
The emergent nature of a cardiac arrest code often demands
expedient administration of IV medications, at times through a
peripheral IV site. This is done, however, with a certain amount
of risk. In the event that extravasation develops, immediately
infiltrate 5 to 10 mg of phentolamine diluted in 10 to 15 mL of
saline into the site of extravasation to prevent tissue necrosis,1 such
as that observed in the above photograph.
■
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Photograph Courtesy of the Wilmington
VA Medical Center.
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